Novel cercosporamide derivative

Details for Australian Patent Application No. 2006277289 (hide)

Owner Daiichi Sankyo Company, Limited

Inventors Satoh, Susumu; Furukawa, Akihiro; Kuroha, Masanori; Ohsumi, Jun; Mori, Makoto; Arita, Tsuyoshi; Honda, Takashi; Okuyama, Ryo; Fukuzaki, Takehiro; Momose, Takayuki; Araki, Kazushi

Agent Davies Collison Cave

Pub. Number AU-A-2006277289

PCT Pub. Number WO2007/018193

Priority 2005-230558 09.08.05 JP; 2005-379060 28.12.05 JP

Filing date 8 August 2006

Wipo publication date 15 February 2007

International Classifications

C07D 307/91 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 31/36 (2006.01)

A61K 31/443 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 407/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/018193 Priority application(s): WO2007/018193

8 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006277295-Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLAA2-positive patients and pharmaceutical comprising the same

2006277253-Pyridone compound